BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$63.06
+0.35%Margins
Gross margin
70.2%
EBITDA margin
33.9%
EBIT margin
28.3%
Net margin
18.9%
FCF margin
23.3%
41.6%
Return on equity
10.6%
Return on assets
21.2%
Return on invested capital
0.57x
Asset turnover
$12.8B
Cash from operations
$5.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026